Lv11
86 积分 2025-11-18 加入
Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors
57分钟前
已关闭
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
8天前
已完结
[Clinical characteristics of adult patients with eosinophilic esophagitis in China]
11天前
已完结
[Diagnosis and management of eosinophilic esophagitis: current status and updates]
13天前
已完结
Abbreviated guidelines for scoring the Cumulative Illness Rating Scale (CIRS) in family practice
1个月前
已完结
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
1个月前
已完结
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population
3个月前
已完结
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
3个月前
已完结
Efficacy and safety of Ebronucimab, in patients with primary hypercholesterolemia and mixed hyperlipidemia: Results from a randomized, double-blind, placebo-controlled phase III clinical study
3个月前
已完结
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial
3个月前
已完结
皖公网安备34019202002308
